Patents by Inventor Li Xi

Li Xi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240136612
    Abstract: An apparatus including a battery cell includes an electrode stack. The electrode stack includes an anode electrode, a cathode electrode, and a separator disposed between the anode electrode and the cathode electrode. The apparatus further includes an enclosure configured for encasing and mechanically protecting the electrode stack. The apparatus further includes an electrolyte. The apparatus further includes a thermally conductive and electrically insulated inert fill material located between the electrode stack and the enclosure configured for providing a thermally conductive connection between the electrode stack and the enclosure.
    Type: Application
    Filed: October 19, 2022
    Publication date: April 25, 2024
    Applicant: GM GLOBAL TECHNOLOGY OPERATIONS LLC
    Inventors: Liang Xi, Andrew P. Oury, Li Yang, SriLakshmi Katar
  • Patent number: 11941318
    Abstract: The present application provides an audio and video playing system, a playing method and a playing device. The system comprises: a display device; a directional sound output module configured to output a directional sound signal; a tracking element configured to monitor a target visual area and to monitor the target display area on the display screen; and a processor, connected with the directional sound output module and the tracking element respectively, and configured to acquire a first audio and video data to be output in the target display area, display image information of the first audio and video data in the target display area, and output sound information of the first audio and video data to the directional sound output module such that the directional sound output module output a directional sound signal towards the target visual area.
    Type: Grant
    Filed: April 27, 2021
    Date of Patent: March 26, 2024
    Assignees: Beijing BOE Optoelectronics Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Xiaomang Zhang, Xiangjun Peng, Tiankuo Shi, Chenxi Zhao, Shuo Zhang, Yifan Hou, Yan Sun, Li Tian, Jing Liu, Wei Sun, Zhihua Ji, Yanhui Xi
  • Publication number: 20230369005
    Abstract: A rotary-transmission-target microfocus X-ray source and an X-ray generation method based on the rotary-transmission-target microfocus X-ray source are provided. The X-ray source comprises a chamber, and an electron beam system is installed in the chamber. The electron beam system is arranged on a same side as an anode target rotating shaft. A motor in a rotary anode target system drives an anode target to rotate through a bevel gear transmission device. The microstructure of a target is designed. An electron beam emitted by the electron beam system vertically bombards the metal target of the rotating anode target. A cooling system is configured to cool the anode target.
    Type: Application
    Filed: May 12, 2023
    Publication date: November 16, 2023
    Applicant: Beijing Institute of Technology
    Inventors: Li XI, Kaiyuan XUE, Daining FANG
  • Patent number: 11817287
    Abstract: A rotary-transmission-target microfocus X-ray source and an X-ray generation method based on the rotary-transmission-target microfocus X-ray source are provided. The X-ray source comprises a chamber, and an electron beam system is installed in the chamber. The electron beam system is arranged on a same side as an anode target rotating shaft. A motor in a rotary anode target system drives an anode target to rotate through a bevel gear transmission device. The microstructure of a target is designed. An electron beam emitted by the electron beam system vertically bombards the metal target of the rotating anode target. A cooling system is configured to cool the anode target.
    Type: Grant
    Filed: May 12, 2023
    Date of Patent: November 14, 2023
    Assignee: Beijing Institute of Technology
    Inventors: Li Xi, Kaiyuan Xue, Daining Fang
  • Publication number: 20230235070
    Abstract: The present invention relates to a method for treating inflammatory bowel disease (IBD) in a patient, the method comprising administering to the patient an anti-TNF-like ligand 1A (TL1A) antibody in an induction dosing regimen sufficient to improve signs and symptoms of IBD by at least 12 weeks after the start of treatment with the anti-TL1A antibody, said induction dosing regimen comprising a plurality of individual induction doses, wherein the method further comprises administering to the patient a subsequent maintenance dosing regimen after completion of the induction dosing regimen, said maintenance dosing regimen comprising a plurality of individual maintenance doses separated from each other by at least 2 weeks.
    Type: Application
    Filed: June 23, 2021
    Publication date: July 27, 2023
    Inventors: Mary Lynn BANIECKI, Mina HASSAN-ZAHRAEE, Kenneth Eugene HUNG, Gang LI, Li XI, Zhan YE
  • Patent number: 11186594
    Abstract: Provided herein are compounds, compositions, and methods for treating cancer in a subject in need thereof.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: November 30, 2021
    Assignees: CALIFORNIA PACIFIC MEDICAL CENTER, DIGNITY HEALTH
    Inventor: Li-Xi Yang
  • Publication number: 20200277310
    Abstract: Provided herein are compounds, compositions, and methods for treating cancer in a subject in need thereof.
    Type: Application
    Filed: May 19, 2020
    Publication date: September 3, 2020
    Applicants: California Pacific Medical Center, Dignity Health
    Inventor: Li-Xi YANG
  • Publication number: 20190077813
    Abstract: Provided herein are compounds, compositions, and methods for treating cancer in a subject in need thereof; wherein the compound has formula (I): or an N-oxide thereof, or a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing, wherein R1 is H or has a structure of: R3 is H, an optionally substituted C1-C8 alkyl, an optionally substituted 3-10 membered cycloalkyl, an optionally substituted 3-10 membered heterocyclyl, an optionally substituted 6-10 membered aryl, or an optionally substituted 5-10 membered heteroaryl; R5 is H or has a structure of: and R11 and R12 independently is an optionally substituted C1-C8 alkyl.
    Type: Application
    Filed: October 27, 2015
    Publication date: March 14, 2019
    Applicants: California Pacific Medical Center, Dignity Health
    Inventor: Li-Xi YANG
  • Patent number: 10087194
    Abstract: Provided herein are compounds, compositions, and methods for treating cancer in a subject in need thereof.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: October 2, 2018
    Assignees: California Pacific Medical Center, Catholic Healthcare West
    Inventor: Li-Xi Yang
  • Publication number: 20170114076
    Abstract: Provided herein are compounds, compositions, and methods for treating cancer in a subject in need thereof.
    Type: Application
    Filed: October 27, 2015
    Publication date: April 27, 2017
    Inventor: Li-Xi Yang
  • Patent number: 8779138
    Abstract: Camptothecin-based compounds are useful for treating a neoplasm in mammalian subjects by administering such compound to the subjects in combination with radiotherapy, i.e., the treatment of tumors with radioactive substances or radiation from a source external to the subject. Camptothecin-based compounds are modified by positioning at least one electron-affinic group around the camptothecin structure to enhance their value in combination with radiotherapy. New Camptothecin-based compounds are disclosed that are useful for treating cancer by administering the novel compounds alone or in combination with radiotherapy.
    Type: Grant
    Filed: January 24, 2011
    Date of Patent: July 15, 2014
    Assignees: Sutter West Bay Hospital, Catholic Healthcare West
    Inventor: Li-Xi Yang
  • Patent number: 8563537
    Abstract: Camptothecin-based compounds are useful for treating a neoplasm in mammalian subjects by administering such compound to the subjects in combination with radiotherapy, i.e., the treatment of tumors with radioactive substances or radiation from a source external to the subject. Camptothecin-based compounds are modified by positioning at least one electron-affinic group around the camptothecin structure to enhance their value in combination with radiotherapy. New Camptothecin-based compounds are disclosed that are useful for treating cancer by administering the novel compounds alone or in combination with radiotherapy.
    Type: Grant
    Filed: July 29, 2008
    Date of Patent: October 22, 2013
    Assignees: Sutter West Bay Hospital, Catholic Healthcare West
    Inventor: Li-Xi Yang
  • Patent number: 8158809
    Abstract: 4-O esters of podophyllotoxin and 4?-demethylepipodophyllotoxin are provided. The compounds are 4-O esters of an alkanoic acid or substituted alkanoic acid and podophyllotoxin and 4?-demethylepipodophyllotoxin. The compounds are useful for treating cancer.
    Type: Grant
    Filed: August 3, 2009
    Date of Patent: April 17, 2012
    Assignees: Sutter West Bay Hospitals, Catholic Healthcare West
    Inventor: Li-Xi Yang
  • Publication number: 20110184009
    Abstract: Camptothecin-based compounds are useful for treating a neoplasm in mammalian subjects by administering such compound to the subjects in combination with radiotherapy, i.e., the treatment of tumors with radioactive substances or radiation from a source external to the subject. Camptothecin-based compounds are modified by positioning at least one electron-affinic group around the camptothecin structure to enhance their value in combination with radiotherapy. New Camptothecin-based compounds are disclosed that are useful for treating cancer by administering the novel compounds alone or in combination with radiotherapy.
    Type: Application
    Filed: January 24, 2011
    Publication date: July 28, 2011
    Inventor: Li-Xi Yang
  • Patent number: 7875602
    Abstract: Camptothecin-based compounds are useful for treating a neoplasm in mammalian subjects by administering such compound to the subjects in combination with radiotherapy, i.e., the treatment of tumors with radioactive substances or radiation from a source external to the subject. Camptothecin-based compounds are modified by positioning at least one electron-affinic group around the camptothecin structure to enhance their value in combination with radiotherapy. New Camptothecin-based compounds are disclosed that are useful for treating cancer by administering the novel compounds alone or in combination with radiotherapy.
    Type: Grant
    Filed: May 30, 2006
    Date of Patent: January 25, 2011
    Assignees: Sutter West Bay Hospitals, Catholic Healthcare West
    Inventor: Li-Xi Yang
  • Publication number: 20090298870
    Abstract: 4-O esters of podophyllotoxin and 4?-demethylepipodophyllotoxin are provided. The compounds are 4-O esters of an alkanoic acid or substituted alkanoic acid and podophyllotoxin and 4?-demethylepipodophyllotoxin. The compounds are useful for treating cancer.
    Type: Application
    Filed: August 3, 2009
    Publication date: December 3, 2009
    Inventor: Li-Xi Yang
  • Publication number: 20090295658
    Abstract: A loop antenna device is disclosed with an increased number of turns, a large opening area, and a high Q value. The loop antenna device includes: a conductor wound spirally on an insulating substrate, wherein the conductor is constituted by a plurality of loops which are connected and each of which has a substantially rectangular shape with predetermined height and width in a cross-sectional view, and with regard to the adjacent loops of which height portions face each other, a height of the one loop is smaller than a height of the other loop, and a width of the other loop is smaller than a width of the one loop.
    Type: Application
    Filed: May 28, 2009
    Publication date: December 3, 2009
    Inventor: Li Xi
  • Patent number: 7605262
    Abstract: 4-O esters of podophyllotoxin and 4?-demethylepipodophyllotoxin are provided. The compounds are 4-O esters of an alkanoic acid or substituted alkanoic acid and podophyllotoxin and 4?-demethylepipodophyllotoxin. The compounds are useful for treating cancer.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: October 20, 2009
    Assignees: Sutter West Bay Hospitals, Catholic Healthcare West
    Inventor: Li-Xi Yang
  • Publication number: 20090105202
    Abstract: The disclosure provides androsterone derivatives. The derivatives of the disclosure are useful in the treatment of androgen- and estrogen-associated diseases and disorders, including breast cancer.
    Type: Application
    Filed: October 18, 2006
    Publication date: April 23, 2009
    Applicants: CALIFORNIA PACIFIC MEDICAL CENTER, CATHOLIC HEALTHCARE WEST
    Inventor: Li-Xi Yang
  • Publication number: 20080318873
    Abstract: Camptothecin-based compounds are useful for treating a neoplasm in mammalian subjects by administering such compound to the subjects in combination with radiotherapy, i.e., the treatment of tumors with radioactive substances or radiation from a source external to the subject. Camptothecin-based compounds are modified by positioning at least one electron-affinic group around the camptothecin structure to enhance their value in combination with radiotherapy. New Camptothecin-based compounds are disclosed that are useful for treating cancer by administering the novel compounds alone or in combination with radiotherapy.
    Type: Application
    Filed: July 29, 2008
    Publication date: December 25, 2008
    Inventor: Li-Xi YANG